Lucid Diagnostics Stock Forecast - Double Exponential Smoothing
| LUCD Stock | USD 1.21 0.14 13.08% |
Lucid Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Lucid Diagnostics stock prices and determine the direction of Lucid Diagnostics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Lucid Diagnostics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The relative strength index (RSI) of Lucid Diagnostics' share price is at 52. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Lucid Diagnostics, making its price go up or down. Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.09) | EPS Estimate Current Year (0.43) | EPS Estimate Next Year (0.30) | Wall Street Target Price 3.7917 | EPS Estimate Current Quarter (0.09) |
Using Lucid Diagnostics hype-based prediction, you can estimate the value of Lucid Diagnostics from the perspective of Lucid Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The Double Exponential Smoothing forecasted value of Lucid Diagnostics on the next trading day is expected to be 1.21 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.67. Lucid Diagnostics after-hype prediction price | USD 1.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections. Lucid Diagnostics Additional Predictive Modules
Most predictive techniques to examine Lucid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lucid using various technical indicators. When you analyze Lucid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Lucid Diagnostics Double Exponential Smoothing Price Forecast For the 27th of January
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Lucid Diagnostics on the next trading day is expected to be 1.21 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.67.Please note that although there have been many attempts to predict Lucid Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lucid Diagnostics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Lucid Diagnostics Stock Forecast Pattern
| Backtest Lucid Diagnostics | Lucid Diagnostics Price Prediction | Buy or Sell Advice |
Lucid Diagnostics Forecasted Value
In the context of forecasting Lucid Diagnostics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Lucid Diagnostics' downside and upside margins for the forecasting period are 0.01 and 4.58, respectively. We have considered Lucid Diagnostics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Lucid Diagnostics stock data series using in forecasting. Note that when a statistical model is used to represent Lucid Diagnostics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0065 |
| MAD | Mean absolute deviation | 0.0283 |
| MAPE | Mean absolute percentage error | 0.0253 |
| SAE | Sum of the absolute errors | 1.6706 |
Predictive Modules for Lucid Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lucid Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lucid Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lucid Diagnostics After-Hype Price Density Analysis
As far as predicting the price of Lucid Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lucid Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lucid Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lucid Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Lucid Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lucid Diagnostics' historical news coverage. Lucid Diagnostics' after-hype downside and upside margins for the prediction period are 0.06 and 4.55, respectively. We have considered Lucid Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lucid Diagnostics is dangerous at this time. Analysis and calculation of next after-hype price of Lucid Diagnostics is based on 3 months time horizon.
Lucid Diagnostics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Lucid Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lucid Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lucid Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 3.37 | 0.00 | 0.00 | 5 Events / Month | 6 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.21 | 1.21 | 0.00 |
|
Lucid Diagnostics Hype Timeline
Lucid Diagnostics is now traded for 1.21. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Lucid is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.02%. %. The volatility of related hype on Lucid Diagnostics is about 14041.67%, with the expected price after the next announcement by competition of 1.21. About 35.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.77. Lucid Diagnostics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections.Lucid Diagnostics Related Hype Analysis
Having access to credible news sources related to Lucid Diagnostics' direct competition is more important than ever and may enhance your ability to predict Lucid Diagnostics' future price movements. Getting to know how Lucid Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lucid Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RPID | Rapid Micro Biosystems | 0.01 | 14 per month | 3.88 | 0.08 | 12.73 | (6.58) | 27.30 | |
| APYX | Apyx Medical | 0.19 | 9 per month | 2.74 | 0.09 | 8.25 | (4.84) | 21.53 | |
| RCEL | Avita Medical | (0.01) | 6 per month | 2.45 | 0.04 | 6.67 | (4.23) | 16.25 | |
| IRD | Opus Genetics | 0.01 | 10 per month | 3.57 | 0.09 | 6.70 | (6.10) | 26.50 | |
| STSS | Sharps Technology | 0.08 | 9 per month | 0.00 | (0.14) | 10.45 | (11.26) | 39.53 | |
| AVR | Anteris Technologies Global | (0.20) | 11 per month | 4.21 | 0.04 | 9.42 | (7.84) | 25.09 | |
| SEER | Seer Inc | 0.01 | 8 per month | 0.00 | (0.14) | 3.41 | (3.06) | 9.98 | |
| OWLT | Owlet Inc | 0.06 | 19 per month | 4.37 | 0.12 | 9.52 | (8.09) | 30.32 | |
| IXHL | Incannex Healthcare Ltd | (0.39) | 3 per month | 0.00 | (0.02) | 11.76 | (7.14) | 26.74 | |
| SCLX | Scilex Holding | 0.00 | 0 per month | 0.00 | (0.14) | 10.30 | (8.23) | 28.87 |
Other Forecasting Options for Lucid Diagnostics
For every potential investor in Lucid, whether a beginner or expert, Lucid Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lucid Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lucid. Basic forecasting techniques help filter out the noise by identifying Lucid Diagnostics' price trends.Lucid Diagnostics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lucid Diagnostics stock to make a market-neutral strategy. Peer analysis of Lucid Diagnostics could also be used in its relative valuation, which is a method of valuing Lucid Diagnostics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lucid Diagnostics Market Strength Events
Market strength indicators help investors to evaluate how Lucid Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lucid Diagnostics shares will generate the highest return on investment. By undertsting and applying Lucid Diagnostics stock market strength indicators, traders can identify Lucid Diagnostics entry and exit signals to maximize returns.
Lucid Diagnostics Risk Indicators
The analysis of Lucid Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lucid Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lucid stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.37 | |||
| Semi Deviation | 2.89 | |||
| Standard Deviation | 3.31 | |||
| Variance | 10.96 | |||
| Downside Variance | 11.92 | |||
| Semi Variance | 8.37 | |||
| Expected Short fall | (2.80) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Lucid Diagnostics
The number of cover stories for Lucid Diagnostics depends on current market conditions and Lucid Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lucid Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lucid Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lucid Diagnostics Short Properties
Lucid Diagnostics' future price predictability will typically decrease when Lucid Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lucid Diagnostics often depends not only on the future outlook of the potential Lucid Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lucid Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.5 M | |
| Cash And Short Term Investments | 22.4 M |
Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections. For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.033 | Return On Assets | Return On Equity |
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.